Based on scientific procedures and safety assessment criteria established by the US FDA, the panel conducted an extensive safety, toxicology and clinical research data obtained from animal and human testing.
"Safety is of course the most important factor for food ingredients and this GRAS finding by independent experts is an important validation of Superba's safety for foods and supplements," stated Nils Hoem, PhD, Chief Scientist at Aker BioMarine.
"The safety of Superba Krill Oil has been exhaustively demonstrated, and this GRAS process is an important step in validating the studies we have conducted on our products. Superba is a minimally processed whole food harvested from the pristine Antarctic waters."
The ingredient can be used as an omega-3 source in a range of foods, including beverages, cereals, cheese, dairy products, and other nutritional foods.
"The health benefits demonstrated by Superba Krill phospholipid EPA & DHA in clinical research will now be available in food applications," added Hoem. "Now the superior bio-efficiency, tolerability, and stability provided by krill's phospholipid omega-3 fatty acids will benefit consumers in convenient food products."